0
     

Report Added
Report already added
Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027

Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027

The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging economies, improving regulatory and reimbursement scenario, and the growing adoption of molecular diagnostics and personalized medicines are expected to offer a wide range of growth opportunities for players in the market. However, the high cost of automated instruments is expected to hinder the growth of the market.

As the world becomes more connected, collaboration and cooperation are needed to reduce the impact of future epidemics. To reduce the risk of future epidemics, increasing research is being conducted across the globe. For instance, the National Institutes of Health (US) invests USD 40 billion annually in health innovation and is expected to spend billions more on COVID- 19 research. Similarly, the UK government has decided to increase its R&D spending over the next three years to reach USD 28.82 billion (GBP 22 billion) by 2024–25. Countries in Asia, such as China and India, have also increased investments in their healthcare and pharmaceutical sectors.

“The instruments segment will grow at the highest rate during the forecast period.”

On the basis ofproduct, the nucleic acid isolation and purification market is segmented intokits, reagents, and instruments. In 2021, kits were the largest product segment in the market. Growth in this market can be attributed to the continuous focus of key market players on developing and launching new and advanced kits. However, the instruments segment is expected to grow at the highest rate during the forecast period.

“By type, the plasmid DNA isolation and purification segment accounted for the largest share of the nucleic acid isolation and purification market in 2021.”

On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation andpurification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types. The plasmid DNA isolation segment accounted for the largest share of the nucleic acid isolation and purification market in 2021.The large share of this market segment can be attributed to the wide use of purified plasmid DNA in a variety of downstream applications, such as PCR, sequencing, expression of proteins, gene therapy, and transfection.

“The market in the Asia Pacificis projected to witness the highest growth rate during the forecast period (2020–2027).”

North America accounted for the largest share of the nucleic acid isolation and purification market in 2021. Significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region are the key factors driving the growth of the nucleic acid isolation and purification market in North America. On the other hand, the Asia Pacificis projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the increasing number of genomic projects and increasing R&D investments by pharmaceutical & biotechnology companies in this region.

A breakdown of the primary participants referred to for this report is provided below:
•By Company Type (Supply-side): Tier 1(29%), Tier 2(37%), and Tier 3(34%)
•By Category (Demand-side): Pharmaceutical & Biotechnology Companies (38%), Hospitals& Diagnostic Centers (30%), and Academic &Government Research Institutes (22%), and Other End Users (10%)
•By Designation: C-level(37%), Director-level(23%), and Managers(40%)
•By Region: North America(37%), Europe(30%), Asia Pacific(21%), and the RoW(12%)

QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the leading players in the global nucleic acid isolation and purification market. Other notable players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GEHealthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany).

Research Coverage:
The report analyzes the nucleic acid isolation and purification market and aims at estimating themarket size and future growth potential of this market based on various segments such as product, method, type, application, end user, and region. The report also includes the competitive analysis of the key players in this market, along with their company profiles, product & service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would helpthemgarner a greater share. Firms purchasing the report could use one, or a combination of the belowmentioned five strategies.

This report provides insights into the following pointers:
•Market Penetration: Comprehensive information on the product portfolios of the top players in the nucleic acid isolation and purification market. The report analyzes the market based on the product, type, application, end user, and region.
•Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the nucleic acid isolation and purification market.
•Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of nucleic acid isolation and purification solutionsacross regions.
•Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the nucleic acid isolation and purification market.
•Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the nucleic acid isolation and purification market.
Table of Contents

1INTRODUCTION28
1.1OBJECTIVES OF THE STUDY28
1.2MARKET DEFINITION29
1.2.1INCLUSIONS AND EXCLUSIONS29
1.3MARKET SCOPE30
1.3.1MARKETS COVERED30
1.3.2YEARS CONSIDERED FOR THE STUDY30
1.4CURRENCY31
1.5LIMITATIONS31
1.6STAKEHOLDERS31
1.7SUMMARY OF CHANGES31
2RESEARCH METHODOLOGY33
2.1RESEARCH DATA33
FIGURE 1RESEARCH DESIGN33
2.1.1SECONDARY DATA34
2.1.1.1Key data from secondary sources34
2.1.2PRIMARY DATA35
FIGURE 2PRIMARY SOURCES35
2.1.2.1Key data from primary sources36
2.1.2.2Breakdown of primary sources36
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION,
AND REGION36
2.2MARKET SIZE ESTIMATION37
FIGURE 4MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS37
FIGURE 5ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC (2021)37
2.3MARKET GROWTH RATE PROJECTIONS39
FIGURE 6NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: CAGR PROJECTION39
2.4MARKET BREAKDOWN AND DATA TRIANGULATION40
FIGURE 7DATA TRIANGULATION METHODOLOGY40
2.5MARKET SHARE ESTIMATION41
2.6ASSUMPTIONS FOR THE STUDY41
2.7LIMITATIONS FOR RESEARCH41
3EXECUTIVE SUMMARY42
FIGURE 8NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION)42
FIGURE 9NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,
2022 VS. 2027 (USD MILLION)43
FIGURE 10NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION)44
FIGURE 11NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)45
FIGURE 12NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER,
2022 VS. 2027 (USD MILLION)46
FIGURE 13GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET47
4PREMIUM INSIGHTS48
4.1NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW48
FIGURE 14TECHNOLOGICAL ADVANCEMENTS AND INCREASED AUTOMATION TO DRIVE MARKET GROWTH48
4.2NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT (2021)49
FIGURE 15KITS TO DOMINATE NORTH AMERICAN NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS MARKET IN 202149
4.3GEOGRAPHICAL SNAPSHOT OF NUCLEIC ACID ISOLATION AND PURIFICATION MARKET50
FIGURE 16JAPAN TO WITNESS HIGHEST MARKET GROWTH RATE FROM 2022 TO 202750
4.4NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION51
FIGURE 17NORTH AMERICA TO DOMINATE MARKET IN 202751
4.5NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEVELOPED VS. DEVELOPING MARKETS52
FIGURE 18DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE
IN FORECAST PERIOD52
5MARKET OVERVIEW53
5.1MARKET DYNAMICS53
FIGURE 19NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES53
5.1.1DRIVERS54
5.1.1.1Increasing R&D activities54
5.1.1.2Technological advancements and increasing automation55
5.1.2RESTRAINTS55
5.1.2.1High cost of automated instruments55
5.1.3OPPORTUNITIES55
5.1.3.1High scope of growth in emerging economies55
5.1.3.2Improving regulatory and reimbursement scenario56
5.1.3.3Molecular diagnostics and personalized medicine56
5.1.4TRENDS57
5.1.4.1Increase in government funding57
5.2COVID-19 IMPACT ON THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET57
5.3PORTER’S FIVE FORCES ANALYSIS58
TABLE 1PORTER’S FIVE FORCES ANALYSIS58
5.3.1THREAT FROM NEW ENTRANTS59
5.3.2THREAT FROM SUBSTITUTES59
5.3.3BARGAINING POWER OF SUPPLIERS59
5.3.4BARGAINING POWER OF BUYERS59
5.3.5DEGREE OF COMPETITION59
5.4TECHNOLOGY ANALYSIS59
5.5SUPPLY CHAIN ANALYSIS61
FIGURE 20SUPPLY CHAIN ANALYSIS: NUCLEIC ACID ISOLATION AND
PURIFICATION MARKET61
6NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE62
6.1INTRODUCTION63
TABLE 2NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2019–2021 (USD MILLION)63
TABLE 3NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2022–2027 (USD MILLION)64
6.2PLASMID DNA ISOLATION AND PURIFICATION64
6.2.1PLASMID DNA ISOLATION AND PURIFICATION ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET64
TABLE 4PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2019–2021 (USD MILLION)65
TABLE 5PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2022–2027 (USD MILLION)66
6.3TOTAL RNA ISOLATION AND PURIFICATION66
6.3.1TOTAL RNA ISOLATION AND PURIFICATION SEGMENT TO
REGISTER STEADY GROWTH66
TABLE 6TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2019–2021 (USD MILLION)67
TABLE 7TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2022–2027 (USD MILLION)67
6.4GENOMIC DNA ISOLATION AND PURIFICATION68
6.4.1GENOMIC DNA ISOLATION IS THE FIRST STEP IN GENETIC-BASED TESTS68
TABLE 8GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2019–2021 (USD MILLION)68
TABLE 9GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2022–2027 (USD MILLION)69
6.5MESSENGER RNA ISOLATION AND PURIFICATION69
6.5.1MESSENGER RNA ISOLATION AND PURIFICATION IS MAINLY USED IN THE STUDY OF GENE EXPRESSION AND TRANSCRIPTOMICS69
TABLE 10MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)70
TABLE 11MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)70
6.6CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION71
6.6.1CLINICAL APPLICATIONS TO DRIVE THE MARKET FOR CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION71
TABLE 12CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY REGION, 2019–2021 (USD MILLION)71
TABLE 13CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY REGION, 2022–2027 (USD MILLION)72
6.7MICRORNA ISOLATION AND PURIFICATION72
6.7.1MICRORNA KITS PROVIDE RAPID ISOLATION AND PURIFICATION OF
RNA MOLECULES FROM SAMPLES72
TABLE 14MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2019–2021 (USD MILLION)73
TABLE 15MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2022–2027 (USD MILLION)73
6.8PCR CLEANUP74
6.8.1TIME-CONSUMING LABORATORY PROCEDURES TO LIMIT THE GROWTH OF THIS MARKET DURING THE FORECAST PERIOD74
TABLE 16PCR CLEANUP MARKET, BY REGION, 2019–2021 (USD MILLION)74
TABLE 17PCR CLEANUP MARKET, BY REGION, 2022–2027 (USD MILLION)74
6.9OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES75
TABLE 18OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET,
BY REGION, 2019–2021 (USD MILLION)75
TABLE 19OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET,
BY REGION, 2022–2027 (USD MILLION)76
7NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD77
7.1INTRODUCTION78
TABLE 20NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,
2019–2021 (USD MILLION)78
TABLE 21NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,
2022–2027 (USD MILLION)78
7.2COLUMN-BASED ISOLATION AND PURIFICATION79
7.2.1COLUMN-BASED ISOLATION AND PURIFICATION IS LARGEST SEGMENT
OF MARKET79
TABLE 22COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)79
TABLE 23COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)80
7.3MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION80
7.3.1MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT
TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD80
TABLE 24MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET,
BY REGION, 2019–2021 (USD MILLION)81
TABLE 25MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET,
BY REGION, 2022–2027 (USD MILLION)81
7.4REAGENT-BASED ISOLATION AND PURIFICATION81
7.4.1REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH BETWEEN 2022 AND 202781
TABLE 26REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)82
TABLE 27REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)82
7.5OTHER ISOLATION AND PURIFICATION METHODS83
TABLE 28OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2019–2025 (USD MILLION)83
TABLE 29OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2022–2027 (USD MILLION)83
8NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT84
8.1INTRODUCTION85
TABLE 30NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT,
2019–2021 (USD MILLION)85
TABLE 31NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT,
2022–2027 (USD MILLION)85
8.2KITS86
8.2.1KITS WERE THE LARGEST PRODUCT SEGMENT IN THE MARKET IN 202186
TABLE 32NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2019–2021 (USD MILLION)86
TABLE 33NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2022–2027 (USD MILLION)87
8.3REAGENTS87
8.3.1REAGENTS SEGMENT TO GROW AT A STEADY RATE DURING
THE FORECAST PERIOD87
TABLE 34NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET,
BY REGION, 2019–2021 (USD MILLION)88
TABLE 35NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET,
BY REGION, 2022–2027 (USD MILLION)88
8.4INSTRUMENTS89
8.4.1AUTOMATED INSTRUMENTS ENABLE A FASTER, CLEANER, AND MORE CONSISTENT NUCLEIC ACID EXTRACTION PROCESS89
TABLE 36NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,
BY REGION, 2019–2021 (USD MILLION)89
TABLE 37NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,
BY REGION, 2022–2027 (USD MILLION)90
9NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION91
9.1INTRODUCTION92
TABLE 38NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019–2021 (USD MILLION)92
TABLE 39NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2022–2027 (USD MILLION)92
9.2DIAGNOSTICS93
9.2.1DIAGNOSTIC APPLICATIONS FORM THE LARGEST AND FASTEST-GROWING SEGMENT IN THE MARKET93
TABLE 40NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019–2021 (USD MILLION)93
TABLE 41NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2027 (USD MILLION)94

9.3DRUG DISCOVERY & DEVELOPMENT94
9.3.1NGS BENEFITS DRUG DISCOVERY APPLICATIONS IN VARIOUS
THERAPEUTIC AREAS94
TABLE 42NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019–2021 (USD MILLION)95
TABLE 43NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2027 (USD MILLION)95
9.4PERSONALIZED MEDICINE96
9.4.1RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE SEGMENT GROWTH96
TABLE 44NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2019–2021 (USD MILLION)96
TABLE 45NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2022–2027 (USD MILLION)97
9.5AGRICULTURE & ANIMAL RESEARCH97
9.5.1FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH97
TABLE 46NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2019–2021 (USD MILLION)98
TABLE 47NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2022–2027 (USD MILLION)98
9.6OTHER APPLICATIONS99
TABLE 48NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2021 (USD MILLION)99
TABLE 49NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2027 (USD MILLION)100
10NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER101
10.1INTRODUCTION102
TABLE 50NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2019–2021 (USD MILLION)102
TABLE 51NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2022–2027 (USD MILLION)102
10.2HOSPITALS & DIAGNOSTIC CENTERS103
10.2.1RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH103
TABLE 52NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2019–2021 (USD MILLION)104
TABLE 53NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2027 (USD MILLION)104
10.3ACADEMIC & GOVERNMENT RESEARCH INSTITUTES104
10.3.1INCREASE IN RESEARCH INTENSITY TO DRIVE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS104
TABLE 54NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019–2021 (USD MILLION)105
TABLE 55NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2022–2027 (USD MILLION)106
10.4PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES106
10.4.1INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS TO DRIVE SEGMENT GROWTH106
TABLE 56NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,
2019–2021 (USD MILLION)107
TABLE 57NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,
2022–2027 (USD MILLION)107
10.5CONTRACT RESEARCH ORGANIZATIONS107
10.5.1CONTRACT RESEARCH ORGANIZATIONS ARE EXPECTED TO REGISTER STEADY GROWTH DURING FORECAST PERIOD107
TABLE 58NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019–2021 (USD MILLION)108
TABLE 59NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022–2027 (USD MILLION)108
10.6OTHER END USERS108
TABLE 60NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2019–2021 (USD MILLION)109
TABLE 61NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR
OTHER END USERS, BY REGION, 2022–2027 (USD MILLION)109
11NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION110
11.1INTRODUCTION111
TABLE 62NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION,
2020–2027 (USD MILLION)111
11.2NORTH AMERICA111
FIGURE 21NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT112
TABLE 63NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)113
TABLE 64NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION)113
TABLE 65NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION)113
TABLE 66NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION)114
TABLE 67NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)114
TABLE 68NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION)115
11.2.1US115
11.2.1.1Government and private funding to support market growth115
TABLE 69US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)116
TABLE 70US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)116
TABLE 71US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2020–2027 (USD MILLION)117
TABLE 72US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)117
TABLE 73US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)118
11.2.2CANADA118
11.2.2.1Growing investments in genomics to boost market demand118
TABLE 74CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION)119
TABLE 75CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION)119
TABLE 76CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)120
TABLE 77CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)120
TABLE 78CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION)121
11.3EUROPE121
TABLE 79EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)121
TABLE 80EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION)122
TABLE 81EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION)122
TABLE 82EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)123
TABLE 83EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)123
TABLE 84EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION)124
11.3.1GERMANY124
11.3.1.1Germany to dominate market in Europe124
TABLE 85CANCER INCIDENCE IN GERMANY, BY TYPE, 2020 VS. 2027125
TABLE 86GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION)125
TABLE 87GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION)126
TABLE 88GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)126
TABLE 89GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)127
TABLE 90GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION)127
11.3.2UK127
11.3.2.1Government support for research through investments, funds, and grants to support market growth127
TABLE 91UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)128
TABLE 92UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)128
TABLE 93UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2020–2027 (USD MILLION)129
TABLE 94UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)129
TABLE 95UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)130
11.3.3FRANCE130
11.3.3.1High cancer burden to drive market growth130
TABLE 96FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION)131
TABLE 97FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION)131
TABLE 98FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)132
TABLE 99FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)132
TABLE 100FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION)133
11.3.4REST OF EUROPE133
TABLE 101REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION)134
TABLE 102REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION)134
11.4ASIA PACIFIC135
FIGURE 22ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT135
TABLE 103ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)136
TABLE 104ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION)136
TABLE 105ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION)136
TABLE 106ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION)137
TABLE 107ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)137
TABLE 108ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION)138
11.4.1CHINA138
11.4.1.1China is expected to register the highest growth in the nucleic acid isolation and purification market in the APAC138
TABLE 109CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)139
TABLE 110CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)139
TABLE 111CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)140
TABLE 112CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)140
TABLE 113CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION)141
11.4.2JAPAN141
11.4.2.1Various conferences & workshops are organized to explore various NAIP applications; a key factor driving market growth141
TABLE 114JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)142
TABLE 115JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)142
TABLE 116JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION)143
TABLE 117JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)143
TABLE 118JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION)144
11.4.3INDIA144
11.4.3.1Focused initiatives in the pharmaceutical & biotechnology industries to drive the market growth for NAIP in India144
TABLE 119INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)144
TABLE 120INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)145
TABLE 121INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION)145
TABLE 122INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)146
TABLE 123INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)146
11.4.4REST OF ASIA PACIFIC (ROAPAC)147
TABLE 124ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION)147
TABLE 125ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION)148
TABLE 126ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION)148
TABLE 127ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)149
TABLE 128ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION)149
11.5REST OF THE WORLD150
TABLE 129ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)150
TABLE 130ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)150
TABLE 131ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)150
TABLE 132ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION)151
TABLE 133ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)151
TABLE 134ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)152
11.5.1LATIN AMERICA152
11.5.1.1Increasing cancer cases to drive the demand for cancer diagnostic tests and, in turn, drive market growth for NAIP152
TABLE 135LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION)153
TABLE 136LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION)153
TABLE 137LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION)154
TABLE 138LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)154
TABLE 139LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION)155
11.5.2MIDDLE EAST & AFRICA155
11.5.2.1Lack of research infrastructure to restrict the growth of the NAIP market in this region155
TABLE 140MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)156
TABLE 141MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)156
TABLE 142MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)157
TABLE 143MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)157
TABLE 144MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)158
TABLE 145REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION)158
TABLE 146REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)159
TABLE 147REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION)159
12COMPETITIVE LANDSCAPE160
12.1OVERVIEW160
12.2KEY PLAYER STRATEGIES/RIGHT TO WIN160
FIGURE 23KEY DEVELOPMENTS IN THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2019-2022160
12.3MARKET SHARE ANALYSIS161
FIGURE 24NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE,
BY KEY PLAYER, 2021161
TABLE 148NUCLEIC ACID ISOLATION AND PURIFICATION MARKET:
DEGREE OF COMPETITION161
12.4REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS162
FIGURE 25REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2019–2021162
12.5COMPANY EVALUATION QUADRANT163
12.5.1STARS163
12.5.2EMERGING LEADERS163
12.5.3PERVASIVE PLAYERS163
12.5.4PARTICIPANTS163
FIGURE 26NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION QUADRANT, 2021164
12.6COMPANY EVALUATION QUADRANT: START-UPS/SMES165
12.6.1PROGRESSIVE COMPANIES165
12.6.2STARTING BLOCKS165
12.6.3RESPONSIVE COMPANIES165
12.6.4DYNAMIC COMPANIES165
FIGURE 27NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021166
12.7COMPANY FOOTPRINT ANALYSIS167
12.7.1COMPANY PRODUCT FOOTPRINT167
TABLE 149COMPANY PRODUCT FOOTPRINT: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET (2021)167
12.8COMPANY REGIONAL FOOTPRINT168
TABLE 150COMPANY REGIONAL FOOTPRINT: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET (2021)168
12.9COMPETITIVE SCENARIO169
TABLE 151PRODUCT LAUNCHES169
TABLE 152DEALS169
TABLE 153OTHER DEVELOPMENTS170
13COMPANY PROFILES171
13.1MAJOR PLAYERS171
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1THERMO FISHER SCIENTIFIC, INC.171
TABLE 154THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW171
FIGURE 28THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)172
13.1.2MERCK KGAA176
TABLE 155MERCK KGAA: BUSINESS OVERVIEW176
FIGURE 29MERCK KGAA: COMPANY SNAPSHOT (2021)177
13.1.3QIAGEN182
TABLE 156QIAGEN: BUSINESS OVERVIEW182
FIGURE 30QIAGEN: COMPANY SNAPSHOT (2021)183
13.1.4F. HOFFMANN-LA ROCHE AG186
TABLE 157F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW186
FIGURE 31F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2021)187
13.1.5GENERAL ELECTRIC COMPANY191
TABLE 158GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW191
FIGURE 32GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2021)192
13.1.6PROMEGA CORPORATION194
TABLE 159PROMEGA CORPORATION: BUSINESS OVERVIEW194
13.1.7AGILENT TECHNOLOGIES, INC.197
TABLE 160AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW197
FIGURE 33AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021)198
13.1.8DANAHER CORPORATION201
TABLE 161DANAHER CORPORATION: BUSINESS OVERVIEW201
FIGURE 34DANAHER CORPORATION: COMPANY SNAPSHOT (2021)202
13.1.9BIO-RAD LABORATORIES, INC.205
TABLE 162BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW205
FIGURE 35BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)206
13.1.10ILLUMINA, INC.208
TABLE 163ILLUMINA, INC.: BUSINESS OVERVIEW208
FIGURE 36ILLUMINA, INC.: COMPANY SNAPSHOT (2021)209
13.1.11TAKARA BIO, INC.211
TABLE 164TAKARA BIO, INC.: BUSINESS OVERVIEW211
13.1.12NEW ENGLAND BIOLABS215
TABLE 165NEW ENGLAND BIOLABS: BUSINESS OVERVIEW215
13.1.13OMEGA BIO-TEK, INC.217
TABLE 166OMEGA BIO-TEK, INC.: BUSINESS OVERVIEW217
13.1.14NORGEN BIOTEK219
TABLE 167NORGEN BIOTEK: BUSINESS OVERVIEW219
13.1.15ZYMO RESEARCH221
TABLE 168ZYMO RESEARCH: BUSINESS OVERVIEW221
13.2OTHER COMPANIES224
13.2.1GENAXXON BIOSCIENCE GMBH224
TABLE 169GENAXXON BIOSCIENCE GMBH: COMPANY OVERVIEW224
13.2.23D BLACKBIO BIOTECH INDIA LTD.225
TABLE 1703D BLACKBIO BIOTECH INDIA LTD.: COMPANY OVERVIEW225
13.2.3INVITEK MOLECULAR GMBH226
TABLE 171INVITEK MOLECULAR GMBH: COMPANY OVERVIEW226
13.2.4BIOVISION228
TABLE 172BIOVISION: COMPANY OVERVIEW228
13.2.5ANALYTIK JENA AG229
TABLE 173ANALYTIK JENA AG: COMPANY OVERVIEW229
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14APPENDIX230
14.1DISCUSSION GUIDE230
14.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL235
14.3AVAILABLE CUSTOMIZATIONS235
14.4RELATED REPORTS236
14.5AUTHOR DETAILS237

Report Title: Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW